We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Handheld Pen Enables Real-Time Tissue Identification during Surgery

By LabMedica International staff writers
Posted on 30 Aug 2023

Thyroid and parathyroid gland surgeries pose significant challenges, even for experienced surgeons. More...

These relatively small neck structures share characteristics like color and texture, complicating visual differentiation. For instance, during thyroid removal procedures, accidental parathyroid removal occurs in about 25% of cases. Similarly, unsuccessful parathyroid removals often result from the inability to locate and resect diseased parathyroid tissue, as thyroid nodules and lymph nodes can be mistaken for parathyroid tissue. There is a critical need for innovative methods to preserve healthy tissue and ensure precise resection.

In a new project, surgeons at Baylor College of Medicine (Houston, TX, USA) extensively tested the MasSpec Pen during thyroid and parathyroid surgeries. In the operating room, the MasSpec Pen helps surgeons identify tissues for resection before actually performing the procedure, ensuring accurate tissue removal without unnecessary damage. Integrating seamlessly into the surgical workflow, the pen can be sterilized like other instruments and simply connected to the mass spectrometer. Its intuitive use holds immense potential for saving time during surgery. The pen primarily detects small molecules like metabolites (cell metabolism byproducts) and lipids created by cells. Each tissue has a unique metabolite and lipid pattern. While many molecules are similar across tissues, their concentrations vary based on tissue type, enabling surgeons to differentiate tissues. The process is simple: the surgeon places the pen gently on the tissue, which deposits a droplet of room-temperature sterile water, extracting small molecules. The droplet is then directed to a real-time mass spectrometer that reveals the tissue's molecular composition, indicating its type. Importantly, this procedure does not harm the analyzed tissues.

In order to assess the precision of this novel technology, the scientists conducted a comparison between the tissue identification outcomes produced by the MasSpec Pen and the well-established method of tissue identification—pathology analysis. Pathologists are experts who specialize in microscopically discerning tissue samples. The MasSpec Pen exhibited exceptional accuracy in distinguishing thyroid, parathyroid, and lymph node tissues during surgeries, achieving accuracy rates exceeding 90%. Results from the MasSpec Pen analysis were available in around 20 seconds, whereas processing samples for pathology analysis (referred to as frozen section) during surgery can extend to an hour, thus saving both procedure time and cost. Typically, prolonged surgeries heighten the risk of complications. The use of the MasSpec Pen offers the benefit of real-time tissue identification during surgical procedures, enhancing patient care.

“The MasSpec Pen could be applied to surgeries of other organs, such as lungs or pancreas,” said co-corresponding author Dr. James Suliburk, associate professor of surgery and member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. “We think this can really revolutionize how we do surgery.”

Related Links:
Baylor College of Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Automated Urinalysis Solution
UN-9000
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.